# FDA Inspection 1214326 - Octapharma Plasma Inc - August 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/7b9aa257-1992-4bc9-b09b-04688a5dc96c
Source feed: FDA_Inspections

> FDA Inspection 1214326 for Octapharma Plasma Inc on August 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214326
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-08-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/2ff67ed1-20f0-4d8d-bf7e-c5d3282322a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d